Leukemia and Lymphoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer (NCT04730349) | Bristol-Myers Squibb | 2021-06-03 |
Track Leukemia and Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.